1-3 of 3
Bradley P. Dixon
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Two-Year Efficacy and Safety of Ravulizumab in Adults and Children with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of Two Phase 3 Studies

Bradley P. Dixon, Alvaro Domingo Madris-Aris, Brigitte Adams, David Kavanagh, Hee Gyung Kang, Jimmy Wang, Katherine Garlo, Kazuki Tanaka, Laurence Greenbaum, Masayo Ogawa, Nils Heyne, Seong Heon Kim, Spero Cataland, Sung-Soo Yoon, Yoshitaka Miyakawa, Yosu Luque, Melissa Muff-Luett
Journal: Blood
Blood (2021) 138 (Supplement 1): 769.
https://doi.org/10.1182/blood-2021-145040
Published: 2021
Journal Articles

Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy

Sonata Jodele, Christoph Licht, Jens Goebel, Bradley P. Dixon, Kejian Zhang, Theru A. Sivakumaran, Stella M. Davies, Fred G. Pluthero, Lily Lu, Benjamin L. Laskin
Journal: Blood
Blood (2013) 122 (12): 2003–2007.
https://doi.org/10.1182/blood-2013-05-501445
Published: 2013
Journal Articles

Long-Term Outcome in a Pediatric Patient with Atypical Hemolytic Uremic Syndrome (aHUS) with Sustained Eculizumab (ECU) Treatment

Ralph A. Gruppo, MD, Bradley P Dixon, MD
Journal: Blood
Blood (2011) 118 (21): 4682.
https://doi.org/10.1182/blood.V118.21.4682.4682
Published: 2011